Multitarget protection of Qiju Dihuang Formula in early-stage diabetic retinopathy is associated with modulation of gut microbiota-derived SCFAs/GPR43/GLP-1/GLP-1R signaling

Background Diabetic retinopathy (DR) is a major microvascular complication of diabetes mellitus and is increasingly recognized as a systemic neurovascular disorder associated with metabolic dysregulation and chronic inflammation. Accumulating evidence suggests that gut microbiota imbalance and impaired gut-derived endocrine signaling contribute to DR progression. Qiju Dihuang Formula (QDF), a traditional Chinese botanical drug prescription, has long been used for visual disorders and metabolic imbalance, yet its multitarget protective mechanisms in DR remain unclear. This study therefore aimed to investigate the protective effects of QDF in a type 2 diabetes–associated early-stage DR mouse model and to explore the association of these effects with gut microbiota modulation and gut microbiota–derived endocrine signaling. Methods A type 2 diabetes–associated DR model was established in C57BL/6J mice using a high-fat diet combined with low-dose streptozotocin. Mice were treated with low, medium, or high doses of QDF for 8 weeks. Metabolic parameters were assessed, retinal function and structure were evaluated, gut microbiota composition was analyzed by 16S rRNA sequencing, fecal short-chain fatty acids (SCFAs) were quantified, and intestinal barrier integrity and related signaling pathways were examined. Results QDF treatment significantly alleviated hyperglycemia and metabolic disturbances in a dose-dependent manner. Retinal electrophysiological dysfunction, microvascular abnormalities, and structural damage were markedly attenuated, particularly at medium and high doses. 16S rRNA sequencing revealed that QDF reshaped gut microbiota composition, modulated fecal SCFA concentrations, and enhanced intestinal barrier integrity. Moreover, QDF treatment was associated with increased intestinal expression of G protein–coupled receptor 43 (GPR43), elevated circulating glucagon-like peptide-1 (GLP-1), and preserved retinal glucagon-like peptide-1 receptor (GLP-1R) expression. Conclusion Collectively, these findings suggest that QDF exerts multitarget protective effects against early-stage DR, and these effects are associated with modulation of gut microbiota–derived SCFAs/GPR43/GLP-1/GLP-1R signaling, systemic metabolic homeostasis, and retinal neurovascular integrity. However, causal relationships remain to be established by future loss-of-function and gain-of-function experiments. This study provides experimental support for the traditional use of QDF in diabetes-related visual disorders.

Authors

Institutions

Publication Details

Journal
Frontiers in Pharmacology
Published
2026-11-13
DOI
https://doi.org/10.3389/fphar.2026.1989764
Primary Topic
Retinal Diseases and Treatments
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

Multitarget protection of Qiju Dihuang Formula in early-stage diabetic retinopathy is associated with modulation of gut microbiota-derived SCFAs/GPR43/GLP-1/GLP-1R signaling

Ge Zhang, Weicheng Xu, Sihan Tao, Jinjin Yu et al.
4 links
Frontiers in Pharmacology
Retinal Diseases and Treatments
article

Multitarget protection of Qiju Dihuang Formula in early-stage diabetic retinopathy is associated with modulation of gut microbiota-derived SCFAs/GPR43/GLP-1/GLP-1R signaling

Ge Zhang, Weicheng Xu, Sihan Tao, Jinjin Yu, Siya Zhang, Wei Shi, Zehai Chen, Guangcheng Ma, Wei Zhang
article en

Abstract

Background Diabetic retinopathy (DR) is a major microvascular complication of diabetes mellitus and is increasingly recognized as a systemic neurovascular disorder associated with metabolic dysregulation and chronic inflammation. Accumulating evidence suggests that gut microbiota imbalance and impaired gut-derived endocrine signaling contribute to DR progression. Qiju Dihuang Formula (QDF), a traditional Chinese botanical drug prescription, has long been used for visual disorders and metabolic imbalance, yet its multitarget protective mechanisms in DR remain unclear. This study therefore aimed to investigate the protective effects of QDF in a type 2 diabetes–associated early-stage DR mouse model and to explore the association of these effects with gut microbiota modulation and gut microbiota–derived endocrine signaling. Methods A type 2 diabetes–associated DR model was established in C57BL/6J mice using a high-fat diet combined with low-dose streptozotocin. Mice were treated with low, medium, or high doses of QDF for 8 weeks. Metabolic parameters were assessed, retinal function and structure were evaluated, gut microbiota composition was analyzed by 16S rRNA sequencing, fecal short-chain fatty acids (SCFAs) were quantified, and intestinal barrier integrity and related signaling pathways were examined. Results QDF treatment significantly alleviated hyperglycemia and metabolic disturbances in a dose-dependent manner. Retinal electrophysiological dysfunction, microvascular abnormalities, and structural damage were markedly attenuated, particularly at medium and high doses. 16S rRNA sequencing revealed that QDF reshaped gut microbiota composition, modulated fecal SCFA concentrations, and enhanced intestinal barrier integrity. Moreover, QDF treatment was associated with increased intestinal expression of G protein–coupled receptor 43 (GPR43), elevated circulating glucagon-like peptide-1 (GLP-1), and preserved retinal glucagon-like peptide-1 receptor (GLP-1R) expression. Conclusion Collectively, these findings suggest that QDF exerts multitarget protective effects against early-stage DR, and these effects are associated with modulation of gut microbiota–derived SCFAs/GPR43/GLP-1/GLP-1R signaling, systemic metabolic homeostasis, and retinal neurovascular integrity. However, causal relationships remain to be established by future loss-of-function and gain-of-function experiments. This study provides experimental support for the traditional use of QDF in diabetes-related visual disorders.

Frontiers in PharmacologyVol. 17
Nanjing University of Chinese Medicine (CN), Jiangsu Provincial Hospital of Traditional Chinese Medicine (CN)
Good health and well-being
Retinal Diseases and Treatments
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon